1,041 results on '"Rupprecht R"'
Search Results
152. Editorial
153. Impact of lipid raft integrity on GABAA receptor function and its modulation by benzodiazepines
154. Astrocytes and neurons coordinate their responsiveness to antidepressant treatment to modulate synaptic plasticity
155. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
156. Modulation of Ligand-Gated Ion Channels as a Novel Pharmacological Principle
157. Major depression, cardiovascular risk factors and the Omega-3 index
158. Roboter zur Demontage
159. The frailty syndrome in general practitioner care
160. S33-01 - Modulation of Ligand Gated Ion Channels by Antidepressants
161. PW01-262 - Influence Of Age On Effectiveness And Tolerability Of Electroconvulsive Therapy
162. PW01-44 - Impact of Glyoxalase-1 Mrna Expression On Cck-4 Induced Anxiety
163. Effects of the GABA-reuptake Inhibitor Tiagabine on Panic and Anxiety in Patients with Panic Disorder
164. A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression
165. Editorial
166. Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants
167. Reliabilität der statischen Posturografie bei älteren Personen
168. Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls
169. Depressive Kernsymptome
170. Thyroid response to dexamethasone: A study on normal controls and patients with psychogenic sexual dysfunction: Der Einfluß von Dexamethason auf die Schilddrüsenfunktion bei Patienten mit erektiler Dysfunktion und gesunden Männern
171. Functional neuroanatomy of CCK-4 induced panic attacks: indications for specifically anxiety-related brain activity
172. Effects of experimentally induced panic attacks on neuroimmunological markers
173. Independent Component Analysis Applied to Pharmacological Magnetic Resonance Imaging (phMRI): New Insights Into the Functional Networks Underlying Panic Attacks as Induced by CCK-4
174. S.24.04 Neuroactive steroids in affective disorders
175. The role of global cerebral hypoperfusion in the development of postoperative cognitive dysfunction
176. Impact of Gene-Gender Effects of Adrenergic Polymorphisms on Hypothalamic-Pituitary-Adrenal Axis Activity in Depressed Patients
177. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder
178. Late adverse effects after soft X‐ray therapy of cutaneous malignancies: pruritus, burning, epiphora and insufficient occlusion of the mouth
179. S.23.03 ACE gene polymorphisms and depression: relation to cardiovascular disease
180. P.4.f.002 Effects of experimentally induced panic attacks on neuroimmunological markers
181. Association between SNPs in the promoter region of the tryptophan hydroxylase 2 gene (TPH2) and the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression
182. Aripiprazole has both agonistic and antagonistic effects on the dopaminergic system in endocrinological challenge tests
183. Acute prefrontal rTMS increases striatal dopamine to a similar degree as d-amphetamine
184. Functional neuroanatomy of CCK-4 induced panic attacks in healthy volunteers
185. Functional Consequences of the accumulation of psychopharmacological drugs in „lipid rafts“ on ligand-gated ion channels
186. Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response
187. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression
188. Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery
189. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression
190. Late side‐effects with cosmetic relevance following soft X‐ray therapy of cutaneous neoplasias
191. Neuropsychological profile of adult patients with Niemann–Pick C1 (NPC1) mutations
192. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients
193. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: Preliminary results of a dynamic [123I] IBZM SPECT study
194. Neuroactive steroids as modulators of depression and anxiety
195. P.1.c.047 A double-blind, placebo-controlled investigation of the anxiolytic effects of XBD173 (AC-5216) and alprazolam using a CCK-4-induced panic challenge
196. Glucocorticoid receptors on mononuclear leukocytes in Alzheimer's disease
197. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity
198. Neuroactive steroids as modulators of depression and anxiety
199. Association between the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression and polymorphisms in the brain derived neurotropic factor (BDNF) and neurotrophic tyrosine kinase receptor 2 (NTRK2) gene
200. The combined T3/TRH-test in depressed patients and healthy controls
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.